Amylyx Pharmaceuticals Inc (United States) is listed on the Nasdaq and has a market capitalization of $3.12 billion, with shareholders equity totaling $239.17 million.
The company employs approximately 154 people and operates in the Others sector, within the Others industry.
Over the past 12 months, Amylyx Pharmaceuticals Inc reported $- in revenue, generating net income of $-152.09 million.
Key financial metrics include a P/E ratio of -20.51, a price-to-book (P/B) ratio of 13.04, and a trailing twelve-month dividend yield of 0.00%.
The company trades under the ticker AMLX.